Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Craving in Nicotine Dependence
NCT07852832Phase 2Not yet recruiting
- Sponsor
- University of British Columbia
- Start
- Jan 2027
- Primary completion
- Dec 2027
01
Overview
A Phase 2 trial of psilocybin in nicotine dependence, sponsored by University of British Columbia. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
psilocybin
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT07852832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07852832.